BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 6391889)

  • 1. Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.
    Ward A; Heel RC
    Drugs; 1984 Nov; 28(5):426-64. PubMed ID: 6391889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bumetanide: A preliminary report of its pharmacological properties and therapeutic efficacy in oedema.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1975; 9(1):4-18. PubMed ID: 1126304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Clissold SP; Brogden RN
    Drugs; 1985 Jun; 29(6):489-530. PubMed ID: 3891305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology, therapeutic efficacy, and adverse effects of bumetanide, a new "loop" diuretic.
    Flamenbaum W; Friedman R
    Pharmacotherapy; 1982; 2(4):213-22. PubMed ID: 6763204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bumetanide in congestive heart failure.
    Kourouklis C; Christensen O; Augoustakis D
    Curr Med Res Opin; 1976; 4(6):422-31. PubMed ID: 793779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ethacrynic acid, bumetanide, frusemide, spironolactone and ADH on electrolyte excretion in ponies.
    Alexander F
    J Vet Pharmacol Ther; 1982 Sep; 5(3):153-60. PubMed ID: 7143552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bumetanide: a new loop diuretic (Bumex, Roche Laboratories).
    Halstenson CE; Matzke GR
    Drug Intell Clin Pharm; 1983 Nov; 17(11):786-97. PubMed ID: 6357686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.
    Roberts CJ; Homeida M; Roberts F; Bogie W
    Br J Clin Pharmacol; 1978 Aug; 6(2):129-33. PubMed ID: 678389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA; Buckley MM
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of bumetanide.
    Cohen M
    J Clin Pharmacol; 1981; 21(11):537-42. PubMed ID: 7338563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diuretic action of bumetanide in advanced chronic renal insufficiency.
    Berg KJ; Tromsdal A; Wideroe TE
    Eur J Clin Pharmacol; 1976 Feb; 9(4):265-75. PubMed ID: 786692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular bumetanide and furosemide in congestive heart failure.
    Abrams J
    J Clin Pharmacol; 1981; 21(11):673-9. PubMed ID: 7338578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bumetanide and frusemide: a comparison of dose-response curves in healthy men.
    Ramsay LE; McInnes GT; Hettiarachchi J; Shelton J; Scott P
    Br J Clin Pharmacol; 1978 Mar; 5(3):243-7. PubMed ID: 656269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Torasemide. An update of its pharmacological properties and therapeutic efficacy.
    Dunn CJ; Fitton A; Brogden RN
    Drugs; 1995 Jan; 49(1):121-42. PubMed ID: 7705212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of diuretic effects along the loop of Henle: an in vivo microperfusion study in rats.
    Unwin RJ; Walter SJ; Giebisch G; Capasso G; Shirley DG
    Clin Sci (Lond); 2000 Apr; 98(4):481-8. PubMed ID: 10731484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.
    Cohen MR; Hinsch E; Vergona R; Ryan J; Kolis SJ; Schwartz MA
    J Pharmacol Exp Ther; 1976 Jun; 197(3):697-702. PubMed ID: 932999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
    Sagar S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the sites and mechanisms of action of bumetanide in man.
    Jayakumar S; Puschett JB
    J Pharmacol Exp Ther; 1977 Apr; 201(1):251-8. PubMed ID: 850144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the acute vascular effects of frusemide and bumetanide.
    Johnston GD; Nicholls DP; Kondowe GB; Finch MB
    Br J Clin Pharmacol; 1986 Apr; 21(4):359-64. PubMed ID: 3518770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrolyte excretion patterns. Intravenous and oral doses of bumetanide compared to furosemide.
    Brater DC; Fox WR; Chennavasin P
    J Clin Pharmacol; 1981; 21(11):599-603. PubMed ID: 7338569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.